InnoTherapy Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - InnoTherapy Inc

Watchlist Manager

Watchlist

Price: 1 994 KRW -0.8% Market Closed

Market Cap: ₩67.8B

I	InnoTherapy Inc KOSDAQ:246960	KR
	Eagle Financial Services Inc NASDAQ:EFSI	US
M	M Vision PCL SET:MVP	TH
	Montagne et Neige Developpement SA PAR:ALMND	FR
V	VC Inc KOSDAQ:365900	KR
V	Vector Science and Therapeutics Corp XTSX:PAIN	CA
T	Tulive Developers Ltd BSE:505285	IN
P	Patriot Gold Corp CNSX:PGOL	US
	Triterras Inc OTC:TRIRF	SG
	Bodhi Tree Multimedia Ltd NSE:BTML	IN
R	Rex Sealing & Packing Industries Ltd BSE:543744	IN
J	Jamf Holding Corp F:JA4	US
	Badger Capital Corp XTSX:TIGR	CA
	Koyosha Inc TSE:7946	JP
O	Orford Mining Corp XTSX:ORM	CA
	Fountain SA XBRU:FOU	BE
	Nitro Software Ltd ASX:NTO	AU
	Taiko Bank Ltd TSE:8537	JP
M	Minehub Technologies Inc OTC:MHUBF	CA
T	Toray Textiles Thailand PCL SET:TTT	TH
	Bolt Biotherapeutics Inc NASDAQ:BOLT	US
A	Aldel Financial II Inc NASDAQ:ALDF	US
M	Megado Gold Ltd ASX:MEG	AU
C	CNL Capital EKES AIFM ATHEX:CNLCAP	GR

Profitability Summary

InnoTherapy Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

18%

Sustainable 3Y Average Gross Margin

25%

Gross Margin is Increasing

17% > 18%

Negative Operating Margin

-10%

Negative 3Y Average Operating Margin

-140%

Operating Margin is Increasing

-683% > -10%

Negative Net Margin

-12%

Negative 3Y Average Net Margin

-149%

Net Margin is Increasing

-1 234% > -12%

Negative Free Cash Flow Margin

-15%

Negative 3Y Average Free Cash Flow Margin

-203%

Free Cash Flow Margin is Increasing

-800% > -15%

Negative ROE

-13%

Negative 3Y Average ROE

Negative 3Y Average ROIC